Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study

Background  Onychomycosis is a common disease; topical treatment is usually poorly effective, while systemic treatment is more effective but may be associated with side‐effects. Iontophoretic drug delivery may improve drug penetration through the nail and lead to better therapeutic results.

[1]  S. N. Murthy,et al.  Trans-ungual iontophoretic delivery of terbinafine. , 2009, Journal of pharmaceutical sciences.

[2]  S. K. Li,et al.  Mechanistic study of electroosmotic transport across hydrated nail plates: effects of pH and ionic strength. , 2008, Journal of pharmaceutical sciences.

[3]  Kelly A. Smith,et al.  Chemical method to enhance transungual transport and iontophoresis efficiency. , 2008, International journal of pharmaceutics.

[4]  H. Trau,et al.  Onychomycosis: rationalization of topical treatment. , 2008, The Israel Medical Association journal : IMAJ.

[5]  S. K. Li,et al.  Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis. , 2008, Journal of pharmaceutical sciences.

[6]  R. Hay,et al.  Review of antifungal therapy and the severity index for assessing onychomycosis: Part I , 2008, The Journal of dermatological treatment.

[7]  J. Garduno,et al.  Review of antifungal therapy, part II: Treatment rationale, including specific patient populations , 2008, The Journal of dermatological treatment.

[8]  N. Ho.  Professor William I. Higuchi: teacher and scientist. , 2008, Journal of pharmaceutical sciences.

[9]  S. N. Murthy,et al.  Iontophoretic permselective property of human nail. , 2007, Journal of dermatological science.

[10]  D. Wiskirchen,et al.  Iontophoretic drug delivery across human nail. , 2007, Journal of pharmaceutical sciences.

[11]  C. Janaki,et al.  Prevalence of dermatophytes and other fungal agents isolated from clinical samples. , 2006, Indian journal of medical microbiology.

[12]  B. Elewski,et al.  Onychomycosis: Pathogenesis, Diagnosis, and Management , 1998, Clinical Microbiology Reviews.

[13]  N. Wilson,et al.  Oral antifungal agents for onychomycosis , 1998, The Lancet.

[14]  G. Petrányi,et al.  Antifungal activity of the allylamine derivative terbinafine in vitro , 1987, Antimicrobial Agents and Chemotherapy.